Dasiglucagon 4 mg/ml
ZP4207-17106
Phase 3 small_molecule active
Quick answer
Dasiglucagon 4 mg/ml for Children with congenital hyperinsulinism is a Phase 3 program (small_molecule) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zealand Pharma A/S
- Indication
- Children with congenital hyperinsulinism
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active